维普中文期刊产品整合服务
35篇 您的检索式:作者名="MAKER AV"
    题名 作者 年代 出处 被引量
1Cytology from pancreatic cysts has marginal utility in surgical decision-making 显示文摘Maker AV Lee LS Rant CP 2008Ann Surg Oncol2008,15,11:1
2Cytology from pancreatic cysts has marginal utility in surgical decision-making 显示文摘Maker AV Lee LS Raut CP 2008Ann Surg Oncol2008,15,11:1
3Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockades and interleukin 2: a phase Ⅰ/Ⅱ study显示文摘Maker AV Phan GQ Attia P 2005Ann Surg Oncol2005,12,12:1
4DD3:a new prostate-specific gene highly overexpressed in prostate cancer显示文摘Busse makers MJG Bok hoven AV Verhaegh GW 1999Cancer Res1999,59,:1
5Inability of a fusion protein of IL-2 and diphtheria toxin ( Denileukin Diftitox, DAB3891L-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma 显示文摘Attia P Maker AV Haworth LR Rogers-Freezer L Rosenberg SA 2005J hmnunother2005,28,6:1
6Cytology from pancreatic cysts has marginal utility in surgical decision-making 显示文摘Maker AV Lee LS Raut CP 2008Ann Surg Oncol2008,15,11:1
7Is port site resection necessary in the surgical management of gallbladder cancer? 显示文摘MAKER AV BUTTE JM OXENBERG J 2011Laparoendosc Adv Surg Tech A2011,21,6:1
8Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2 显示文摘Atria P Powell DJ Jr Maker AV 2006J Immunother2006,29,2:1
9Rapid acute amiodarone-induced hepatotoxicity in a burn patient显示文摘Maker AV Orgill DP 2005J Burn Care Rehabil2005,26,4:1
10Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade 显示文摘Maker AV Attia P Rosenberg SA 2005J Immunol2005,175,11:1
11Cytology from pancreatic cysts has marginal utility in surgical decision-making显示文摘Maker AV Lee LS Raut CP 2008Ann Surg Oncol2008,15,11:1
12Cytology from pancreatic cysts has marginal utility in surgical decision-making显示文摘Maker AV Lee LS Raut CP 2008Ann Surg On- col2008,15,11:1
13Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox,DAB389IL-2,ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma显示文摘Attia P Maker AV Haworth LR 2005J Immunother2005,28,6:1
14Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anticytotoxic T-lymphocyte antigen-4 显示文摘Attia P Phan GQ Maker AV 2005J Clin Oncol2005,23,:1
15Malignant masquerade of xanthogranul-omatous cholecystitis on intraoperative ultrasound of the liver显示文摘Maker AV Maker VK 2012J Surg Oncol2012,106,4:1
16Rapid acute amiodarone-induced hepatotoxicity in a burn patient显示文摘Maker AV Orgill DP 2005J Burn Care Rehabil2005,26,4:1
17Tumor regression and auto- immunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase Ⅰ/Ⅱ study 显示文摘Maker AV Phan GQ Attia P 2005Ann Surg Oncol2005,12,:1
18Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma显示文摘Maker AV Yang JC Sherry RM 2006J Immunother2006,29,4:1
19Inability of afusion protein of IL-2 and diphtheria toxin (DenileukinDiftitox, DAB389IL-2, ONTAK) to eliminate regulatory Tlymphocytes in patients with melanoma 显示文摘Attia P Maker AV Haworth LR 2005J Immunother2005,28,6:1
20Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases显示文摘Katz SC Bamboat ZM Maker AV 0,,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费